Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks
Advanced Healthcare Materials · 2023-07 · 12 (19)
DOI: 10.1002/adhm.202202984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 12.05.2023. Verfasst von Emmanouil Angelidakis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Hauptthemen laut MEDLINE: Hemostatics, Neoplasms, Thrombosis. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Norges Idrettshøgskole.
Abstract (Originalsprache)
A bidirectional association exists between metastatic dissemination and the hypercoagulable state associated with many types of cancer. As such, clinical studies have provided evidence that markers associated with elevated levels of coagulation and fibrinolysis correlate with decreased patient survival. However, elucidating the mechanisms underpinning the effects of different components of the coagulation system on metastasis formation is challenging both in animal models and 2D models lacking the complex cellular interactions necessary to model both thrombosis and metastasis. Here, an in vitro, 3D, microvascular model for observing the formation of fibrin thrombi is described, which is in turn used to study how different aspects of the hypercoagulable state associated with cancer affect the endothelium. Using this platform, cancer cells expressing ICAM‐1 are shown to form a fibrinogen‐dependent bridge and transmigrate through the endothelium more effectively. Cancer cells are also demonstrated to interact with fibrin thrombi, using them to adhere, spread, and enhance their extravasation efficiency. Finally, thrombin is also shown to enhance cancer cell extravasation. This system presents a physiologically relevant model of fibrin clot formation in the human microvasculature, enabling in‐depth investigation of the cellular interactions between cancer cells and the coagulation system affecting cancer cell extravasation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, 02215, USA.
ORCID-Profile: Emmanouil Angelidakis, Sarah E Shelton
Förderung
- NCI NIH HHS
- Norges Idrettshøgskole
Zitieren
APA
Angelidakis, E., Chen, S., Zhang, S., Wan, Z., Kamm, R. D., & Shelton, S. E. (2023). Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks. Advanced Healthcare Materials, 12(19). https://doi.org/10.1002/adhm.202202984
Vancouver
Angelidakis E, Chen S, Zhang S, Wan Z, Kamm RD, Shelton SE. Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks. Advanced Healthcare Materials. 2023;12(19). doi:10.1002/adhm.202202984
BibTeX
@article{Angelidakis2023,
author = {Angelidakis, Emmanouil and Chen, Sophia and Zhang, Shun and Wan, Zhengpeng and Kamm, Roger D and Shelton, Sarah E},
title = {Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {19},
doi = {10.1002/adhm.202202984}
}
EUVIMED